Cargando…
GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice
GV1001, a 16 amino acid peptide derived from the catalytic segment of human telomerase reverse transcriptase, was developed as an anti-cancer vaccine. Subsequently, it was found to exhibit anti-inflammatory and anti-Alzheimer’s disease properties. Periodontitis is a risk factor for a variety of syst...
Autores principales: | Kim, Sharon Y., Kim, Yun-Jeong, Kim, Suyang, Momeni, Mersedeh, Lee, Alicia, Treanor, Alexandra, Kim, Sangjae, Kim, Reuben H., Park, No-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454325/ https://www.ncbi.nlm.nih.gov/pubmed/37628753 http://dx.doi.org/10.3390/ijms241612566 |
Ejemplares similares
-
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
por: Kim, Shin Hye, et al.
Publicado: (2018) -
hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF-β signaling
por: Chen, Wei, et al.
Publicado: (2018) -
Protective effects of GV1001 on myocardial ischemia-reperfusion injury
por: Chang, Ji-Eun, et al.
Publicado: (2017) -
Rosuvastatin Prevents the Exacerbation of Atherosclerosis in Ligature-Induced Periodontal Disease Mouse Model
por: Suh, Jin Sook, et al.
Publicado: (2020) -
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016)